The emerging therapy of the medication represents a exciting development in the handling of type 2 diabetes. Distinct from existing drugs, tirzepatide targets two pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide681408.mybuzzblog.com/22120362/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment